Eos Management L.P. raised its holdings in shares of Waters Co. (NYSE:WAT - Free Report) by 31.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,790 shares of the medical instruments supplier's stock after purchasing an additional 2,589 shares during the quarter. Waters accounts for approximately 1.7% of Eos Management L.P.'s portfolio, making the stock its 14th largest position. Eos Management L.P.'s holdings in Waters were worth $4,003,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Advisory Alpha LLC boosted its holdings in Waters by 2.6% during the 4th quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier's stock worth $395,000 after acquiring an additional 27 shares during the last quarter. Summit Trail Advisors LLC boosted its holdings in Waters by 2.4% during the third quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier's stock worth $431,000 after purchasing an additional 28 shares during the last quarter. Empowered Funds LLC grew its position in Waters by 3.0% in the 4th quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier's stock worth $358,000 after purchasing an additional 28 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. increased its stake in Waters by 0.3% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier's stock valued at $3,565,000 after buying an additional 30 shares during the last quarter. Finally, OneDigital Investment Advisors LLC increased its stake in Waters by 3.8% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier's stock valued at $306,000 after buying an additional 31 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.
Waters Price Performance
Waters stock traded down $3.89 during midday trading on Thursday, reaching $369.25. 131,337 shares of the stock were exchanged, compared to its average volume of 438,138. The company's fifty day moving average is $391.20 and its 200-day moving average is $369.80. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56. The firm has a market cap of $21.94 billion, a PE ratio of 34.39, a PEG ratio of 3.79 and a beta of 1.00.
Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, sell-side analysts forecast that Waters Co. will post 12.86 EPS for the current year.
Analyst Ratings Changes
Several research firms have recently issued reports on WAT. JPMorgan Chase & Co. upped their target price on Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Scotiabank raised Waters from a "sector perform" rating to a "sector outperform" rating and raised their target price for the company from $430.00 to $450.00 in a research report on Thursday, February 13th. Bank of America lowered their target price on Waters from $430.00 to $410.00 and set a "neutral" rating on the stock in a research note on Thursday, February 13th. UBS Group increased their price target on shares of Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research report on Thursday, February 13th. Finally, Barclays raised shares of Waters from an "underweight" rating to an "equal weight" rating and lifted their price objective for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Waters currently has an average rating of "Hold" and an average price target of $391.07.
Read Our Latest Research Report on Waters
About Waters
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
